LabCare · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of LabCare is 0.2% (very low). The 2025 annual accounts show equity of €146k and a net result of €69k. Its solvency ranks better than 93% of 2220 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Signals

2 signals · with evidence

Strong solvency vs sector

Solvency is in the sector's strongest quartile: better than 93% of 2220 peers (2025). A comfortable equity buffer.

View the sector comparison

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 18-03-2026, 43 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 2 filed financial years, each closing on 30-09. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-09-2025, that is 30-04-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
30-09-2025	30-04-2026	18-03-2026	43 d early	2026-00056551
30-09-2024	30-04-2025	26-03-2025	35 d early	2025-00056810

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Young company

Founded in 2023, under 3 years, statistically higher risk.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€69k-5.9%

Working capital€136k+95.8%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 18-03-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	94.9%	58.1%	better than 93% of 2220 sector peers
Net result	€69k	€60k	better than 55% of 2218 sector peers
Equity	€146k	€74k	better than 68% of 2220 sector peers
Gross operating margin	€101k	€95k	better than 52% of 2220 sector peers
Total assets	€153k	€187k	better than 42% of 2220 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€101k

-4.8% 24-25

Net profit

€69k

-5.9% 24-25

Cash flow

€71k

-6.4% 24-25

Total assets

€153k

+62.4% 24-25

Equity

€146k

+90.4% 24-25

Working capital

€136k

+95.8% 24-25

Income taxes

€28k

-4.6% 24-25

Debt

€8k

-56.7% 24-25

Show 8 other metrics

Debt ≤ 1y

€8k

-56.7% 24-25

Current ratio

18.40

+279.2% 24-25

Quick ratio

18.40

+279.2% 24-25

Solvency

94.9%

+17.3% 24-25

Debt / equity

0.05

-77.2% 24-25

ROE

47.5%

-50.6% 24-25

ROA

45.1%

-42.0% 24-25

Interest coverage

41.70

-52.1% 24-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€101k
Net profit	€69k
Cash flow	€71k
Staff costs	-
Income taxes	€28k
Dividends	-
Total assets	€153k
Equity	€146k
Debt	€8k
of which ≤ 1y	€8k
of which > 1y	-
Working capital	€136k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	18.40
Quick ratio	18.40
Working capital ratio	88.6%
Solvency	94.9%
Debt / equity	0.05
Long-term debt ratio	-
Interest coverage	41.70
Gross margin	-
Net margin	-
ROA	45.1%
ROE	47.5%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €10k · 6.3% Current assets €144k · 93.7%

Equity & liabilities

Equity €146k · 94.9% Debt €8k · 5.1%

Full annual accounts (21 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€153k
Fixed assets	21/28	€10k
Tangible fixed assets	22/27	€10k
Current assets	29/58	€144k
Amounts receivable within one year	40/41	€13k
Cash & bank	54/58	€69k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€153k
Equity	10/15	€146k
Contributions / capital	10/11	€3k
Reserves	13	€143k
Amounts payable	17/49	€8k
Amounts payable within one year	42/48	€8k
Trade debts payable within one year	44	€130
Income statement
Gross operating margin	9900	€101k
Operating result	9901	€99k
Financial income	75	€13
Financial charges	65	€2k
Result before taxes	9903	€97k
Income taxes	67/77	€28k
Net result for the period	9904	€69k
Result to be appropriated	9905	€69k

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

93 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

1 location

LabCare

Impasse des Mésanges 2, 5340 GesvesActiviteiten van medisch specialisten

since 20232.351.300.784

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area3,784 m²

Buildings1

Building footprint142 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)